Search results
FibroBiologics Shares Up 38% on Withdrawn Equity Offering
Market Watch· 1 day agoThe stock was up 38% to $9.24 in recent trading. Shares closed at $12.96 on May 29, and declined during the next five trading sessions, touching a 52-week low of $6.42 on Wednesday. Earlier ...
When to Use Retinol vs. Other Retinoids, According to Dermatologists
InStyle· 2 days agoFrom Selena Gomez and Ariana Grande to teens at Sephora, it's hard to find someone who doesn't swear...
Extreme Temperatures Tied to Elevated Stroke Mortality Risk
Medscape· 4 days agoExtreme temperatures are linked to an increased stroke mortality risk, especially for those in...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 4 days agoUNION therapeutics announces successful completion of the ADESOS Phase 2b study and presentation of data at the RAVE Conference 2024 PR Newswire HELLERUP, Denmark, June 4, 2024 ADESOS Phase 2b study evaluating orismilast as an oral treatment in
The 3 Best Biotech Stocks to Buy in June 2024
InvestorPlace· 2 days agoThis was not surprising given the disparity between biotech’s high-capital requirements and rising interest rates set by the Fed. Despite these...
‘Bye-bye, flakes’: This scalp massager with 112,000 five-star fans is on sale for just $7
Yahoo Life Shopping· 7 days agoOr maybe texture where you hold it so it’s not so slick." "I have the kind of greasy hair that is...
AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology...
Benzinga· 4 days agoThe recommended treatment regime with AbbVie's Skyrizi involves an intravenous induction dose of...
Pharma Ad Startup Snags Seed Funding To Support Better TV Ad Targeting | AdExchanger
AdExchanger· 2 days agoPharma brands spend billions of dollars every year on poorly targeted TV advertising. A new startup...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks· 20 hours agoEli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
Izokibep shows promise in psoriatic arthritis trial By Investing.com
Investing.com· 2 days agoACELYRIN, INC. (NASDAQ: SLRN), a biopharmaceutical company specializing in immunology, announced...